| Margaret Wood-mciver, LPN | |
|
195 W 7200 S, Midvale, UT 84047-3703 | |
| (801) 565-6974 | |
| Not Available |
| Full Name | Margaret Wood-mciver |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 195 W 7200 S, Midvale, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699746578 | NPI | - | NPPES |
| 262140 | Other | UT | DESERET MUTUAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 1407263101 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Margaret Wood-mciver, LPN 3324 Terrace View Dr, Salt Lake City, UT 84109-4140 Ph: (801) 485-0125 | Margaret Wood-mciver, LPN 195 W 7200 S, Midvale, UT 84047-3703 Ph: (801) 565-6974 |
News Archive
Lesbian, gay, bisexual, transgender and questioning (LGBTQ) youths are more likely to end up in foster care or unstable housing and suffer negative outcomes, such as substance abuse or mental health issues, while living in the child welfare system, according to new research from The University of Texas at Austin.
A team of researchers from University of California, San Diego, have successfully used gut organoids in their lab to show the effects of medications to treat conditions such as "leaky gut". The study was titled, "The stress polarity signaling (SPS) pathway serves as a marker and a target in the leaky gut barrier: implications in aging and cancer," and was published in the journal Life Science Alliance today.
Researchers at Albert Einstein College of Medicine of Yeshiva University in collaboration with Nurses' Health Study investigators have shown that levels of certain related proteins found in blood are associated with a greatly reduced risk for developing type 2 diabetes up to a decade or more later. The findings, published today in the online edition of Diabetes, could open a new front in the war against diabetes.
Researchers have finally found the genetic targets that could be used for treatment and development of new drugs in patients who are resistant to chemotherapy. These patients who are resistant to chemotherapy are most likely to have triple negative breast cancer which is the most aggressive form of breast cancer. The study appeared in the latest issue of the journal Cell Metabolism.
Researchers at an Alzheimer's Conference in Spain have come up with more information on the disease and just who amongst the population is most likely to get it.
› Verified 4 days ago